220 related articles for article (PubMed ID: 3310744)
1. Effects of pentoxifylline on severe intermittent claudication.
Reich T; Gillings D
Angiology; 1987 Sep; 38(9):651-6. PubMed ID: 3310744
[TBL] [Abstract][Full Text] [Related]
2. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ
Angiology; 1989 Jul; 40(7):639-49. PubMed ID: 2662830
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic treatment of intermittent claudication.
Porter JM; Bauer GM
Surgery; 1982 Dec; 92(6):966-71. PubMed ID: 7147192
[TBL] [Abstract][Full Text] [Related]
4. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
Dettori AG; Pini M; Moratti A; Paolicelli M; Basevi P; Quintavalla R; Manotti C; Di Lecce C
Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578
[TBL] [Abstract][Full Text] [Related]
5. Intermittent claudication: a double-blind crossover trial of pentoxifylline.
Gallus AS; Gleadow F; Dupont P; Walsh J; Morley AA; Wenzel A; Alderman M; Chivers D
Aust N Z J Med; 1985 Aug; 15(4):402-9. PubMed ID: 3866536
[TBL] [Abstract][Full Text] [Related]
6. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
Hood SC; Moher D; Barber GG
CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
Reilly DT; Quinton DN; Barrie WW
N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
[TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline in the treatment of intermittent claudication of the lower limbs.
Reich T; Cutler BC; Lee BY; Porter JM; Reichle FA; Scogin JT; Strandness DE
Angiology; 1984 Jul; 35(7):389-95. PubMed ID: 6380347
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication.
Crowder JE; Cohn JB; Savitsky JP; Morgan DL; Slywka J; Cobert BL; Hryniewicki SW; Piccirillo RT; Wilcox CS
Angiology; 1989 Sep; 40(9):795-802. PubMed ID: 2669564
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.
Porter JM; Cutler BS; Lee BY; Reich T; Reichle FA; Scogin JT; Strandness DE
Am Heart J; 1982 Jul; 104(1):66-72. PubMed ID: 7046409
[TBL] [Abstract][Full Text] [Related]
11. Another look at the pentoxifylline efficacy data for intermittent claudication.
Gillings D; Koch G; Reich T; Stager WJ
J Clin Pharmacol; 1987 Aug; 27(8):601-9. PubMed ID: 3655008
[TBL] [Abstract][Full Text] [Related]
12. A comparison of cilostazol and pentoxifylline for treating intermittent claudication.
Dawson DL; Cutler BS; Hiatt WR; Hobson RW; Martin JD; Bortey EB; Forbes WP; Strandness DE
Am J Med; 2000 Nov; 109(7):523-30. PubMed ID: 11063952
[TBL] [Abstract][Full Text] [Related]
13. Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent claudication.
Di Perri T; Guerrini M
Angiology; 1983 Jan; 34(1):40-5. PubMed ID: 6824189
[TBL] [Abstract][Full Text] [Related]
14. On the assessment of the efficacy of pentoxifylline (Trental).
Rössner M; Müller R
J Med; 1987; 18(1):1-15. PubMed ID: 3298515
[TBL] [Abstract][Full Text] [Related]
15. [Intermittent claudication treated with pentoxifylline. A controlled trial].
Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
[No Abstract] [Full Text] [Related]
16. Pentoxifylline--a new drug for the treatment of intermittent claudication.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
[TBL] [Abstract][Full Text] [Related]
17. Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial.
De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
Angiology; 2002; 53 Suppl 1():S13-7. PubMed ID: 11865829
[TBL] [Abstract][Full Text] [Related]
18. Determinants of response to pentoxifylline therapy in patients with intermittent claudication.
Thomas JH; Swannack CJ; McAnaw M; Klein S; Kinnaman ML; Iliopoulos JI; Hermreck AS; Pierce GE
Am J Surg; 1987 Dec; 154(6):663-5. PubMed ID: 3425814
[TBL] [Abstract][Full Text] [Related]
19. Treatment of severe intermittent claudication with pentoxifylline: a 40-week, controlled, randomized trial.
Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; De Sanctis MT; Incandela L; Geroulakos G; Ramaswami G; Cazaubon M; Barsotti A; Vasdekis S; Bavera P; Ippolito E
Angiology; 2002; 53 Suppl 1():S1-5. PubMed ID: 11865828
[TBL] [Abstract][Full Text] [Related]
20. Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication.
Aviado DM
Ric Clin Lab; 1983; 13 Suppl 3():263-8. PubMed ID: 6143383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
